You are here: Industry Insights > china

News List

China approves anti-cancer agent by Eisai biospectrumasia
July 18, 2019
Halaven is a halichondrin class microtubule dynamics inhibitor with a distinct binding profile.
China announces generic drug list to reduce pharmaceutical costs europeanpharmaceuticalreview
June 26, 2019
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
Inaugural Global Health Forum of Boao Forum for Asia held in China biospectrumasia
June 16, 2019
The Global Health Forum is a comprehensive, representative and authoritative platform for high-level dialogues and practical cooperation in the health field, linking governments, the business community and academia
China approves GSK’s shingles vaccine Shingrix in adults pharmaceutical-technology
May 29, 2019
GlaxoSmithKline (GSK) has received approval from the Chinese National Medical Products Administration (NMPA) for the use of its Shingrix vaccine to prevent shingles (herpes zoster) in adults.
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last? fiercepharma
May 29, 2019
If you follow Big Pharma companies’ investor updates, you’ll notice China popping up frequently these days.
Researcher proposes glaucoma screening in China to reduce blindness biospectrumasia
May 20, 2019
The researchers revealed how a national screening could save government funds in the long-term as well as saving three million years of blindness among the over 50 population.
WuXi Biologics to Build Mfg. Center in Southwest China contractpharma
May 17, 2019
Begins construction of a 48,000L Integrated Manufacturing Center for Innovative Biologics in Chengdu.
Peritech Pharma receives new patents in China, Russia biospectrumasia
May 15, 2019
Treatment of hemorrhoids and anal itching uses slow-release mechanism, offers longer relief to patients with a single treatment per day
Super-blockbuster: Trastuzumab PharmaSources/1℃
May 14, 2019
As one of the three super-blockbusters of Roche, trastuzumab has accumulatively brought over CHF80 billion sales revenue.
Based on China to Go International: The Trastuzumab Biosimilar HLX02 Applied for Marketing PharmaSources/1℃
May 14, 2019
The marketing of the drug in China will mark a milestone.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page